ALLO IPSC

Serial Number 97650057
606

Registration Progress

Application Filed
Oct 27, 2022
Under Examination
May 30, 2023
Approved for Publication
Apr 4, 2023
Published for Opposition
Apr 4, 2023
Registered

Trademark Image

ALLO IPSC

Basic Information

Serial Number
97650057
Filing Date
October 27, 2022
Published for Opposition
April 4, 2023
Abandonment Date
July 1, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 1, 2024
Classes
005

Rights Holder

Allogene Therapeutics, Inc.

03
Address
210 E. Grand Avenue
South San Francisco, CA 94080

Ownership History

Allogene Therapeutics, Inc.

Original Applicant
03
South San Francisco, CA

Allogene Therapeutics, Inc.

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
Jason S. Howell

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

21 events
Date Code Type Description
Jul 12, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 1, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Oct 27, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 25, 2023 EX1G S SOU EXTENSION 1 GRANTED
Oct 25, 2023 EXT1 S SOU EXTENSION 1 FILED
Oct 25, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
May 30, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 4, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 4, 2023 PUBO A PUBLISHED FOR OPPOSITION
Mar 15, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 28, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 28, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED
Feb 28, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 28, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED
Feb 28, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jan 17, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 17, 2023 GNRT F NON-FINAL ACTION E-MAILED
Jan 17, 2023 CNRT R NON-FINAL ACTION WRITTEN
Jan 4, 2023 DOCK D ASSIGNED TO EXAMINER
Nov 10, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 31, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"IPSC"

USPTO Documents

Loading USPTO documents...